- £214.96m
- £257.40m
- £135.14m
- 82
- 29
- 83
- 76
Annual income statement for Redcentric, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 91.4 | 93.3 | 142 | 125 | 135 |
| Cost of Revenue | |||||
| Gross Profit | 57.9 | 59.5 | 101 | 78.2 | 83.3 |
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 78.6 | 86.7 | 151 | 119 | 127 |
| Operating Profit | 12.8 | 6.61 | -8.94 | 5.69 | 8.39 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 11.3 | 5.54 | -12.5 | 1.83 | 4.38 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 9.01 | 6.94 | -9.25 | 1.72 | 2.69 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 9.01 | 6.94 | -9.25 | -3.44 | 3.49 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 9.01 | 6.94 | -9.25 | -3.44 | 3.49 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.079 | 0.05 | -0.025 | 0.02 | 0.02 |
| Dividends per Share |